QQ客服 官方微博 反馈留言

	ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7
	Ting Guo; Xian-Zi Wen; Zi-yu Li; Hai-bo Han; Chen-guang Zhang; Yan-hua Bai; Xiao-Fang Xing; Xiao-jing Cheng; Hong Du; Ying Hu
刊名	Cell Death & Disease
	2019
卷号	Vol.10
ISSN号	2041-4889
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4612172
专题	湖南大学
作者单位	1.000 0001 0027 0586, grid.41247 2.0, Key Laboratory of Carcinogenesis and Translational Research , Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China 3.0000 0001 0027 0586, grid.41247 4.0, Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China 5.0, The Tissue Bank, Peking University Cancer Hospital & Institute, Beijing, China 6.0000 0004 0369 153X, grid.2469 7.3f, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China 8.0, Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China
推荐引用方式 GB/T 7714	Ting Guo,Xian-Zi Wen,Zi-yu Li,et al. ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7[J]. Cell Death & Disease,2019,Vol.10.
APA	Ting Guo.,Xian-Zi Wen.,Zi-yu Li.,Hai-bo Han.,Chen-guang Zhang.,...&Jia-Fu Ji.(2019).ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.Cell Death & Disease,Vol.10.
MLA	Ting Guo,et al."ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7".Cell Death & Disease Vol.10(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。